Janssen Pharmaceuticals Inc.

09/21/2021 | Press release | Distributed by Public on 09/21/2021 05:47

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.